ケロイド治療の世界市場レポート 2025年

ケロイド治療の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.3％で51億7,000万米ドルに成長します。予測期間の成長は、パーソナルケア製品への支出増加、政府の取り組み、傷跡予防戦略への重点化、ケロイド治療への投資などに起因しています。予測期間の主な動向としては、治療方法の進歩、医療技術の革新、ケロイド治療の低侵襲手術の高度化、併用療法、レーザー技術、瘢痕管理製品などが挙げられます。

創傷や傷害の発生率の増加がケロイド治療市場の成長を促進すると予想されます。創傷とは、身体の組織に対する物理的な損傷や損傷のことで、一般的には、事故、手術、火傷、その他の外傷的な出来事など、さまざまな要因によって引き起こされる皮膚の断裂を伴う。創傷の増加はケロイド形成の一因となり、効果的な治療オプションへの需要を高め、ケロイド関連合併症への認識を高め、研究の進歩を促し、医療専門家間の連携を促進します。例えば、2023年12月、米国政府機関である労働統計局のデータによると、米国における死亡労働災害は2022年には5,486件に上り、2021年の5,190件から5.7％増加しました。この増加動向は、労働災害の大幅な増加を浮き彫りにしています。その結果、創傷や傷害の発生率の増加がケロイド治療市場の拡大を促進すると思われます。

非外科的美容処置への関心の高まりがケロイド治療市場を牽引すると予想されます。非外科的美容処置とは、手術をせずに外見を向上させることを目的とした美容治療であり、より若々しい外見のための特定の懸念に対処します。ヘルスケアプロバイダーは、レーザー治療、凍結療法、皮膚充填剤のような非外科的処置を利用して、ケロイド瘢痕の外観や症状を最小限に抑え、炎症、発赤、血管新生を軽減します。例えば、2023年9月、米国を拠点とする組織である国際美容形成外科学会は、2022年に形成外科医が世界で1,490万件以上の外科手術と1,880万件以上の非外科手術を行い、全体で11.2％の増加を示したと報告しました。その結果、非外科的美容処置に対する需要の高まりがケロイド治療市場を前進させると思われます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ケロイド治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のケロイド治療市場：成長率分析
• 世界のケロイド治療市場の実績：規模と成長, 2019-2024
• 世界のケロイド治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界ケロイド治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のケロイド治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 放射線治療
• クライオセラピー
• 外科的治療
• レーザー治療
• ステロイド注射
• インターフェロン
• その他の治療法
• 世界のケロイド治療市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 伸縮性のあるラップ
• スプレー
• 軟膏
• クリーム
• オイル
• 局所用ジェルとジェルシート
• その他の製品
• 世界のケロイド治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• 世界のケロイド治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 皮膚科クリニック
• その他のエンドユーザー
• 世界のケロイド治療市場、放射線治療の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 術後放射線療法
• 手術前放射線療法
• 世界のケロイド治療市場、凍結療法の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 凍結療法
• 凍結療法
• 世界のケロイド治療市場、外科的治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 切除
• 再手術
• 世界のケロイド治療市場、レーザー治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フラクショナルレーザー
• パルス色素レーザー
• 世界のケロイド治療市場ステロイド注射の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• トリアムシノロンアセトニド
• ベタメタゾン
• 世界のケロイド治療市場インターフェロンの種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• インターフェロンアルファ
• インターフェロン-γ
• 世界のケロイド治療市場、その他の治療法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シリコンゲルシート
• 局所治療

第7章 地域別・国別分析

• 世界のケロイド治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のケロイド治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ケロイド治療市場：競合情勢
• ケロイド治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca plc
• GlaxoSmithKline plc.
• Eli Lilly and Company
• Mylan N.V.
• Galderma S.A.
• Sun Pharmaceutical Industries Ltd.
• Molnlycke Health Care AB
• Cynosure Inc.
• Cutera Inc.
• Alliance Pharma plc
• Revance Therapeutics Inc
• Sensus Healthcare
• Strata Skin Sciences
• Avita Medical Limited
• Pacific World Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ケロイド治療市場2029：新たな機会を提供する国
• ケロイド治療市場2029：新たな機会を提供するセグメント
• ケロイド治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Keloids refer to raised, thickened scars that extend beyond the original boundaries of a wound or injury. These scars result from an overgrowth of collagen during the healing process, leading to a firm, often discolored and sometimes uncomfortable or itchy area on the skin. Keloids can be treated using various medical interventions and approaches tailored to the individual's condition and the severity of the keloid.

The main types of keloids treatment are radiation therapy, cryotherapy, surgical treatment, laser treatment, steroid injections, interferon and others. Radiation therapy is a medical treatment that uses high doses of targeted radiation to target and destroy abnormal cells, such as keloid cells, aiming to inhibit the overgrowth of cells and reduce the size of keloids, which helps prevent keloid recurrence by damaging the cells that contribute to their formation. Keloids treatment also includes products such as elastic wraps, sprays, ointments, creams, oils, topical gels and gel sheets and others administered orally and parenterally by end users such as hospitals, homecare, dermatology clinics and others.

The keloids treatment market research report is one of a series of new reports from The Business Research Company that provides keloids treatment market statistics, including keloids treatment industry global market size, regional shares, competitors with a keloids treatment market share, detailed keloids treatment market segments, market trends and opportunities and any further data you may need to thrive in the keloids treatment industry. This keloids treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The keloids treatment market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.37 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to high prevalence of keloids, growing awareness keloid treatments, increasing incidence of wound and injury-related cases, rise in aesthetic surgeries.

The keloids treatment market size is expected to see steady growth in the next few years. It will grow to $5.17 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing expenditure on personal care products, government initiatives, increasing emphasis on scar prevention strategies, investments on keloids treatments. Major trends in the forecast period include advancements in treatment modalities, innovation in medical technologies, adanced minimally invasive procedures on keloids treatment, combination therapies, laser technology, scar management products.

The increasing incidence of wounds and injuries is expected to drive the growth of the keloid treatment market. A wound is a physical injury or damage to the body's tissues, typically involving a break in the skin, caused by various factors such as accidents, surgeries, burns, or other traumatic events. The rise in wound occurrences contributes to keloid formation, heightening the demand for effective treatment options, boosting awareness of keloid-related complications, encouraging research advancements, and fostering collaboration among medical professionals. For instance, in December 2023, data from the Bureau of Labor Statistics, a U.S. government agency, reported that fatal work injuries in the United States rose to 5,486 in 2022, representing a 5.7% increase from 5,190 in 2021. This upward trend highlights a substantial rise in industrial accidents. Consequently, the growing incidence of wounds and injuries will drive expansion in the keloid treatment market.

Growing interest in non-surgical aesthetic procedures is expected to drive the keloid treatment market. Non-surgical aesthetics are cosmetic treatments aimed at enhancing appearance without surgery, addressing specific concerns for a more youthful look. Healthcare providers utilize non-surgical procedures like laser therapy, cryotherapy, and dermal fillers to minimize the appearance and symptoms of keloid scars, reducing inflammation, redness, and vascularization. For example, in September 2023, the International Society of Aesthetic Plastic Surgery, a U.S.-based organization, reported that in 2022, plastic surgeons performed over 14.9 million surgical and 18.8 million non-surgical procedures globally, marking an 11.2% increase overall. Consequently, the rising demand for non-surgical aesthetic procedures will propel the keloid treatment market forward.

Prominent companies operating in the keloid treatment market are strategically focusing on the development of innovative scar management technologies, such as Scar Erase silicone strips, to attain a competitive edge. For instance, in April 2023, Scar Erase, a UK-based scar treatment company, introduced Scar Erase silicone strips as a solution for scar treatment. These strips, composed of 3 mm medical-grade silicone, have demonstrated clinical efficacy in enhancing scar appearance and facilitating healing. They are reusable, vegan, cruelty-free, and offer a convenient and cost-effective at-home scar treatment option suitable for various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. The technology involves encapsulating the scar with silicone to maintain hydration and create an optimal healing environment. This approach reduces collagen formation, improves scar texture, color, and height, delivering both effectiveness and comfort.

In March 2022, Alliance Pharma PLC, a UK-based pharmaceutical company, completed the acquisition of ScarAway from Perrigo Co. PLC for $19.4 million. This acquisition empowered Alliance Pharma to strengthen its presence in the U.S. consumer healthcare market, diversify its product portfolio, establish a global brand, boost revenue, and solidify its position as a market leader in scar treatment. ScarAway, a U.S.-based scar treatment brand specializing in keloids, played a pivotal role in this strategic move.

Major companies operating in the keloids treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Company, Mylan N.V., Galderma S.A., Sun Pharmaceutical Industries Ltd., Molnlycke Health Care AB, Cynosure Inc., Cutera Inc., Alliance Pharma PLC, Revance Therapeutics Inc., Sensus Healthcare, Strata Skin Sciences, Avita Medical Limited, Pacific World Corporation, Mederma, Stratpharma AG, Sonoma Pharmaceuticals Inc., RXi Pharmaceuticals Inc., Biodermis, Novoxel Ltd., Scar Heal Inc., Galena Biopharma Inc.

North America was the largest region in the keloids treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in keloids treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the keloids treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The keloids treatment market consists of revenues earned by entities by providing dermatology consultations, follow-up and monitoring and patient education and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The keloids treatment market also includes sales of topical creams and gels, silicone sheets and patches and dermal fillers, which are used in keloids treatment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Keloids Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on keloids treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for keloids treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The keloids treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Radiation Therapy; Cryo Therapy; Surgical Treatment; Laser Treatment; Steroid Injections; Interferon; Other Treatments
• 2) By Product Type: Elastic Wraps; Sprays; Ointment; Creams; Oils; Topical Gels And Gel Sheets; Other Products
• 3) By Route Of Administration: Oral; Parenteral
• 4) By End User: Hospitals; Homecare; Dermatology Clinics; Other End Users
• Subsegments:
• 1) By Radiation Therapy: Post-Surgical Radiation Therapy; Pre-Surgical Radiation Therapy
• 2) By Cryo Therapy: Cryosurgery; Cryoablation
• 3) By Surgical Treatment: Excision; Revision Surgery
• 4) By Laser Treatment: Fractional Laser; Pulsed Dye Laser
• 5) By Steroid Injections: Triamcinolone Acetonide; Betamethasone
• 6) By Interferon: Interferon-Alpha; Interferon-gamma
• 7) By Other Treatments: Silicone Gel Sheets; Topical Treatments
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Keloids Treatment Market Characteristics

3. Keloids Treatment Market Trends And Strategies

4. Keloids Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Keloids Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Keloids Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Keloids Treatment Market Growth Rate Analysis
• 5.4. Global Keloids Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Keloids Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Keloids Treatment Total Addressable Market (TAM)

6. Keloids Treatment Market Segmentation

• 6.1. Global Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiation Therapy
• Cryo Therapy
• Surgical Treatment
• Laser Treatment
• Steroid Injections
• Interferon
• Other Treatments
• 6.2. Global Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Elastic Wraps
• Sprays
• Ointment
• Creams
• Oils
• Topical Gels And Gel Sheets
• Other Products
• 6.3. Global Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• 6.4. Global Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Dermatology Clinics
• Other End Users
• 6.5. Global Keloids Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Post-Surgical Radiation Therapy
• Pre-Surgical Radiation Therapy
• 6.6. Global Keloids Treatment Market, Sub-Segmentation Of Cryo Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cryosurgery
• Cryoablation
• 6.7. Global Keloids Treatment Market, Sub-Segmentation Of Surgical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Excision
• Revision Surgery
• 6.8. Global Keloids Treatment Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fractional Laser
• Pulsed Dye Laser
• 6.9. Global Keloids Treatment Market, Sub-Segmentation Of Steroid Injections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Triamcinolone Acetonide
• Betamethasone
• 6.10. Global Keloids Treatment Market, Sub-Segmentation Of Interferon, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Interferon-Alpha
• Interferon-gamma
• 6.11. Global Keloids Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Silicone Gel Sheets
• Topical Treatments

7. Keloids Treatment Market Regional And Country Analysis

• 7.1. Global Keloids Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Keloids Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Keloids Treatment Market

• 8.1. Asia-Pacific Keloids Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Keloids Treatment Market

• 9.1. China Keloids Treatment Market Overview
• 9.2. China Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Keloids Treatment Market

• 10.1. India Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Keloids Treatment Market

• 11.1. Japan Keloids Treatment Market Overview
• 11.2. Japan Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Keloids Treatment Market

• 12.1. Australia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Keloids Treatment Market

• 13.1. Indonesia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Keloids Treatment Market

• 14.1. South Korea Keloids Treatment Market Overview
• 14.2. South Korea Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Keloids Treatment Market

• 15.1. Western Europe Keloids Treatment Market Overview
• 15.2. Western Europe Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Keloids Treatment Market

• 16.1. UK Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Keloids Treatment Market

• 17.1. Germany Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Keloids Treatment Market

• 18.1. France Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Keloids Treatment Market

• 19.1. Italy Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Keloids Treatment Market

• 20.1. Spain Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Keloids Treatment Market

• 21.1. Eastern Europe Keloids Treatment Market Overview
• 21.2. Eastern Europe Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Keloids Treatment Market

• 22.1. Russia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Keloids Treatment Market

• 23.1. North America Keloids Treatment Market Overview
• 23.2. North America Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Keloids Treatment Market

• 24.1. USA Keloids Treatment Market Overview
• 24.2. USA Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Keloids Treatment Market

• 25.1. Canada Keloids Treatment Market Overview
• 25.2. Canada Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Keloids Treatment Market

• 26.1. South America Keloids Treatment Market Overview
• 26.2. South America Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Keloids Treatment Market

• 27.1. Brazil Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Keloids Treatment Market

• 28.1. Middle East Keloids Treatment Market Overview
• 28.2. Middle East Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Keloids Treatment Market

• 29.1. Africa Keloids Treatment Market Overview
• 29.2. Africa Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Keloids Treatment Market Competitive Landscape And Company Profiles

• 30.1. Keloids Treatment Market Competitive Landscape
• 30.2. Keloids Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Keloids Treatment Market Other Major And Innovative Companies

• 31.1. AstraZeneca plc
• 31.2. GlaxoSmithKline plc.
• 31.3. Eli Lilly and Company
• 31.4. Mylan N.V.
• 31.5. Galderma S.A.
• 31.6. Sun Pharmaceutical Industries Ltd.
• 31.7. Molnlycke Health Care AB
• 31.8. Cynosure Inc.
• 31.9. Cutera Inc.
• 31.10. Alliance Pharma plc
• 31.11. Revance Therapeutics Inc
• 31.12. Sensus Healthcare
• 31.13. Strata Skin Sciences
• 31.14. Avita Medical Limited
• 31.15. Pacific World Corporation

32. Global Keloids Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Keloids Treatment Market

34. Recent Developments In The Keloids Treatment Market

35. Keloids Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Keloids Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Keloids Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Keloids Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer